| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |